Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

The study will be carried out in partnership with The GOG Foundation and the European Network of Gynecological Oncological ...

Antibody-drug conjugates have emerged as a promising cancer treatment, combining targeted delivery of cytotoxic agents with the specificity of monoclonal antibodies. Despite their potential, ADCs face ...

aDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA bDivision of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA cDivision of ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...